OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Physiology-Lung Cellular and Molecular Physiology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Healing after COVID-19: are survivors at risk for pulmonary fibrosis?	173
The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells	86
The Idiopathic Pulmonary Fibrosis Cell Atlas	81
COPD 2020: changes and challenges	80
Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids’ immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression	70
Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients	62
Inflammasome activation in acute lung injury	58
Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?	49
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures	45
E-cigarette constituents propylene glycol and vegetable glycerin decrease glucose uptake and its metabolism in airway epithelial cells in vitro	44
SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport	42
Identification of lung innervating sensory neurons and their target specificity	41
Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells	40
Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19	40
Altered lung metabolism and mitochondrial DAMPs in lung injury due to acute kidney injury	39
The oxygen dissociation curve of blood in COVID-19	38
Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis	36
COPD 2020: new directions needed	36
Comprehensive review of lipocalin 2-mediated effects in lung inflammation	33
A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure	32
Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia	32
Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities	32
Platelet activation contributes to hypoxia-induced inflammation	31
Erythrocytes identify complement activation in patients with COVID-19	31
Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures	30

TRPC6, a therapeutic target for pulmonary hypertension	29
Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation	26
Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease	26
E-cigarettes and health risks: more to the flavor than just the name	26